Treatment of fibromyalgia with antidepressants
- 1 September 2000
- journal article
- research article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 15 (9) , 659-666
- https://doi.org/10.1046/j.1525-1497.2000.06279.x
Abstract
BACKGROUND: Fibromyalgia is a common, poorly understood musculoskeletal pain syndrome with limited therapeutic options. OBJECTIVE: To systematically review the efficacy of antidepressants in the treatment of fibromyalgia and examine whether this effect was independent of depression. DESIGN: Meta-analysis of English-language, randomized, placebo-controlled trials. Studies were obtained from searching medline, embase, and psyclit (1966-1999), the Cochrane Library, unpublished literature, and bibliographies. We performed independent duplicate review of each study for both inclusion and data extraction. MAIN RESULTS: Sixteen randomized, placebo-controlled trials were identified, of which 13 were appropriate for data extraction. There were 3 classes of antidepressants evaluated: tricyclics (9 trials), selective serotonin reuptake inhibitors (3 trials), and S-adenosylmethionine (2 trials). Overall, the quality of the studies was good (mean score 5.6, scale 0–8). The odds ratio for improvement with therapy was 4.2 (95% confidence interval [95% CI], 2.6 to 6.8). The pooled risk difference for these studies was 0.25 (95% CI, 0.16 to 0.34), which calculates to 4 (95% CI, 2.9 to 6.3) individuals needing treatment for 1 patient to experience symptom improvement. When the effect on individual symptoms was combined, anti-depressants improved sleep, fatigue, pain, and well-being, but not trigger points. In the 5 studies where there was adequate assessment for an effect independent of depression, only 1 study found a correlation between symptom improvement and depression scores. Outcomes were not affected by class of agent or quality score using meta-regression. CONCLUSION: Antidepressants are efficacious in treating many of the symptoms of fibromyalgia. Patients were more than 4 times as likely to report overall improvement, and reported moderate reductions in individual symptoms, particularly pain. Whether this effect is independent of depression needs further study.Keywords
This publication has 47 references indexed in Scilit:
- The Efficacy of Selective Serotonin Reuptake Inhibitors for the Management of Chronic PainJournal of General Internal Medicine, 1997
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- A Randomized Placebo-Controlled Trial of Sustained-Release Amitriptyline in Primary FibromyalgiaJournal of Musculoskeletal Pain, 1996
- Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgiaArthritis & Rheumatism, 1995
- Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairmentArchives of Family Medicine, 1994
- Lack of association between fibromyalgia syndrome and abnormalities in muscle energy metabolismArthritis & Rheumatism, 1994
- Treatment of post-herpetic neuralgia: AntidepressantsAnnals of Neurology, 1994
- Bowel dysfunction in fibromyalgia syndromeDigestive Diseases and Sciences, 1991
- The american college of rheumatology 1990 criteria for the classification of fibromyalgiaArthritis & Rheumatism, 1990
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986